To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD).
We queried a consortium database for patients with IBD receiving SBRT for prostate cancer between 2006 and 2012.
To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD).
We queried a consortium database for patients with IBD receiving SBRT for prostate cancer between 2006 and 2012.